Detalhe da pesquisa
1.
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Ann Oncol
; 35(4): 392-401, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244927
2.
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial.
Ann Oncol
; 32(6): 726-735, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794293
3.
A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.
Ann Oncol
; 31(2): 257-265, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959342
4.
Functional outcome and return to sports after the arthroscopic latarjet procedure in young and physically active patients.
Arch Orthop Trauma Surg
; 140(10): 1487-1494, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524229
5.
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Ann Oncol
; 30(6): 970-976, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050707
6.
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer.
Ann Oncol
; 29(11): 2200-2207, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30202945
7.
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Ann Oncol
; 29(2): 361-369, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077785
8.
Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma.
Br J Cancer
; 117(4): 478-484, 2017 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28683470
9.
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
Ann Oncol
; 28(10): 2481-2488, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961845
10.
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.
Ann Oncol
; 28(11): 2741-2746, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29059273
11.
Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.
World J Urol
; 35(3): 367-378, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342991
12.
Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms.
World J Urol
; 35(4): 641-648, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27488984
13.
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.
Ann Oncol
; 27(2): 286-94, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26578735
14.
Comparing comparators: a look at control arms in kidney cancer studies over the years.
Br J Cancer
; 112(1): 14-9, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25375270
15.
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.
Br J Cancer
; 112(7): 1190-8, 2015 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25695485
16.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Ann Oncol
; 26(8): 1589-604, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041764
17.
Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial.
Ann Oncol
; 25(2): 429-34, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24478320
18.
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Ann Oncol
; 30(11): 1841, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868903
19.
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Ann Oncol
; 30(12): e3, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141017
20.
Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy.
Ann Oncol
; 24(4): 1017-25, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152362